• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于 SEER 计划的上皮性卵巢癌年轻患者总生存和癌症特异性生存的预测列线图分析。

Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Young Patients with Epithelial Ovarian Cancer: Analysis Based on SEER Program.

机构信息

Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, 110004, Liaoning, China.

Department of Gynecology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, 570011, Hainan, China.

出版信息

Adv Ther. 2022 Jan;39(1):257-285. doi: 10.1007/s12325-021-01955-9. Epub 2021 Oct 29.

DOI:10.1007/s12325-021-01955-9
PMID:34716558
Abstract

INTRODUCTION

Currently, there is no clinical prediction model for young patients (≤ 45 years old) with epithelial ovarian cancer (EOC) based on large samples of clinical data. The purpose of this study was to construct nomograms using data extracted from the Surveillance, Epidemiology, and End Results (SEER) Program to predict the overall survival (OS) and cancer-specific survival (CSS) of patients and to further guide the choice of clinical treatment options.

METHODS

Data from a total of 6376 young patients with EOC collected from 1998 to 2016 were selected from the SEER database. These patients were randomly divided (7:3) into a training cohort (n = 4465) and a validation cohort (n = 1911). Cox and least absolute shrinkage and selection operator (LASSO) analyses were used to select the prognostic factors affecting OS and CSS, and the nomograms of OS and CSS were established. The performance of the nomogram models was assessed by C-index, area under the curve (AUC), calibration curves, and decision curve analysis (DCA). Sample were chosen from patients who underwent surgery in Shengjing Hospital to set external validation. Kaplan-Meier curves were plotted to compare survival outcomes between subgroups.

RESULTS

Nomograms showed good predictive power and clinical practicality. The internal and external validation indicated better performance of the nomograms than the American Joint Committee on Cancer (AJCC) staging system and tumor grade system. Significant differences were observed in the survival curves of different risk subgroups.

CONCLUSIONS

We constructed predictive nomograms to evaluate the OS and CSS of young patients with EOC. The nomograms will provide an individualized evaluation of OS and CSS for suitable treatment of young patients with EOC.

摘要

简介

目前,基于大样本临床数据,尚无针对年轻上皮性卵巢癌(EOC)患者(≤45 岁)的临床预测模型。本研究旨在构建使用来自监测、流行病学和最终结果(SEER)计划的数据提取的列线图,以预测患者的总生存期(OS)和癌症特异性生存期(CSS),并进一步指导临床治疗方案的选择。

方法

从 SEER 数据库中选择了 1998 年至 2016 年间共 6376 例年轻 EOC 患者的数据。将这些患者随机分为训练队列(n=4465)和验证队列(n=1911)。采用 Cox 和最小绝对收缩和选择算子(LASSO)分析筛选影响 OS 和 CSS 的预后因素,并建立 OS 和 CSS 的列线图。通过 C 指数、曲线下面积(AUC)、校准曲线和决策曲线分析(DCA)评估列线图模型的性能。从在盛京医院接受手术的患者中选择样本进行外部验证。绘制 Kaplan-Meier 曲线比较不同亚组的生存结果。

结果

列线图显示了良好的预测能力和临床实用性。内部和外部验证表明,列线图的性能优于美国癌症联合委员会(AJCC)分期系统和肿瘤分级系统。不同风险亚组的生存曲线存在显著差异。

结论

我们构建了预测列线图来评估年轻上皮性卵巢癌患者的 OS 和 CSS。该列线图将为年轻上皮性卵巢癌患者的 OS 和 CSS 提供个体化评估,为其提供合适的治疗。

相似文献

1
Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Young Patients with Epithelial Ovarian Cancer: Analysis Based on SEER Program.基于 SEER 计划的上皮性卵巢癌年轻患者总生存和癌症特异性生存的预测列线图分析。
Adv Ther. 2022 Jan;39(1):257-285. doi: 10.1007/s12325-021-01955-9. Epub 2021 Oct 29.
2
Nomograms for predicting overall survival and cancer-specific survival in elderly patients with epithelial ovarian cancer.预测老年上皮性卵巢癌患者总生存和癌症特异性生存的列线图。
J Ovarian Res. 2023 Apr 14;16(1):75. doi: 10.1186/s13048-023-01144-y.
3
Clinical Nomograms for Predicting the Overall Survival and Cancer-specific Survival of patients with Ovarian Carcinosarcoma patients after Primary Surgery.预测原发性手术后卵巢癌肉瘤患者总生存期和癌症特异性生存期的临床列线图
J Cancer. 2021 Oct 25;12(23):7223-7236. doi: 10.7150/jca.63224. eCollection 2021.
4
A novel nomogram based on LODDS to predict the prognosis of epithelial ovarian cancer.一种基于对数优势比(LODDS)的新型列线图,用于预测上皮性卵巢癌的预后。
Oncotarget. 2017 Jan 31;8(5):8120-8130. doi: 10.18632/oncotarget.14100.
5
Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma.卵巢透明细胞癌患者总生存和癌症特异性生存的列线图的建立与验证。
J Ovarian Res. 2020 Oct 17;13(1):123. doi: 10.1186/s13048-020-00727-3.
6
Development and validation of survival nomograms for patients with differentiated thyroid cancer with distant metastases: a SEER Program-based study.基于 SEER 计划的研究:分化型甲状腺癌伴远处转移患者生存列线图的建立与验证。
J Endocrinol Invest. 2024 Jan;47(1):115-129. doi: 10.1007/s40618-023-02129-w. Epub 2023 Jun 9.
7
Establishment and Verification of a Nomogram for Predicting Survival in Patients with Small Intestinal Gastrointestinal Stromal Tumors.小肠胃肠道间质瘤患者生存预测列线图的建立与验证
Dig Dis. 2022;40(1):50-61. doi: 10.1159/000516022. Epub 2021 Mar 22.
8
Nomograms for primary mucinous ovarian cancer: A SEER population-based study.原发性黏液性卵巢癌的列线图:一项基于 SEER 人群的研究。
J Gynecol Obstet Hum Reprod. 2022 Sep;51(7):102424. doi: 10.1016/j.jogoh.2022.102424. Epub 2022 Jun 11.
9
A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis.卵巢黏液性囊腺癌患者的预后模型:基于人群的分析。
J Ovarian Res. 2022 Feb 16;15(1):26. doi: 10.1186/s13048-022-00958-6.
10
Competing risk nomogram and risk classification system for evaluating overall and cancer-specific survival in neuroendocrine carcinoma of the cervix: a population-based retrospective study.基于人群的回顾性研究:用于评估宫颈神经内分泌癌患者总生存和癌症特异性生存的竞争风险列线图和风险分类系统。
J Endocrinol Invest. 2024 Jun;47(6):1545-1557. doi: 10.1007/s40618-023-02261-7. Epub 2024 Jan 3.

引用本文的文献

1
Development and validation of a nomogram for predicting overall and cancer-specific survival in elderly patients (≥ 65 years) with epithelial ovarian cancer.用于预测老年(≥65岁)上皮性卵巢癌患者总生存期和癌症特异性生存期的列线图的开发与验证。
Eur J Med Res. 2025 Sep 1;30(1):831. doi: 10.1186/s40001-025-03114-0.
2
Nomogram for predicting the early death of patients with stage IV ovarian cancer: a retrospective analysis of the SEER database.预测IV期卵巢癌患者早期死亡的列线图:基于监测、流行病学和最终结果(SEER)数据库的回顾性分析
Transl Cancer Res. 2024 Nov 30;13(11):5845-5855. doi: 10.21037/tcr-24-625. Epub 2024 Nov 27.
3

本文引用的文献

1
Controversies in surgical management of advanced ovarian cancer (stage III-IV).晚期卵巢癌(III-IV期)手术治疗中的争议
Eur J Gynaecol Oncol. 2000;21(5):449-60.
Pan-immune-inflammation value: a new prognostic index in epithelial ovarian cancer.
全身性免疫炎症指数:上皮性卵巢癌的一种新的预后指标。
BMC Cancer. 2024 Aug 26;24(1):1052. doi: 10.1186/s12885-024-12809-2.
4
Impact of surgical compliance on survival prognosis of patients with ovarian cancer and associated influencing factors: A propensity score matching analysis of the SEER database.手术依从性对卵巢癌患者生存预后的影响及相关影响因素:基于监测、流行病学和最终结果(SEER)数据库的倾向评分匹配分析
Heliyon. 2024 Jun 25;10(13):e33639. doi: 10.1016/j.heliyon.2024.e33639. eCollection 2024 Jul 15.
5
Effect of different treatment modalities on ovarian cancer patients with liver metastases: A retrospective cohort study based on SEER.不同治疗方式对卵巢癌伴肝转移患者的影响:一项基于 SEER 的回顾性队列研究。
PLoS One. 2024 Apr 18;19(4):e0299504. doi: 10.1371/journal.pone.0299504. eCollection 2024.
6
Development and validation of a prognostic nomogram for predicting cancer-specific survival in advanced endometrial carcinoma after surgery: a retrospective analysis of the SEER Database.基于 SEER 数据库的回顾性分析:用于预测手术后晚期子宫内膜癌患者癌症特异性生存的预后列线图的开发和验证。
BMJ Open. 2023 Sep 15;13(9):e070893. doi: 10.1136/bmjopen-2022-070893.
7
Prognostic Factors and a Predictive Nomogram of Cancer-Specific Survival of Epithelial Ovarian Cancer Patients with Pelvic Exenteration Treatment.盆腔廓清术治疗上皮性卵巢癌患者的预后因素和癌症特异性生存预测列线图。
Int J Clin Pract. 2023 Aug 17;2023:9219067. doi: 10.1155/2023/9219067. eCollection 2023.
8
Risk factors of early mortality in patients with small cell lung cancer: a retrospective study in the SEER database.小细胞肺癌患者早期死亡的风险因素:SEER 数据库中的回顾性研究。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11193-11205. doi: 10.1007/s00432-023-05003-7. Epub 2023 Jun 24.
9
How do serum lipid levels change and influence progression-free survival in epithelial ovarian cancer patients receiving bevacizumab treatment?接受贝伐单抗治疗的上皮性卵巢癌患者的血清脂质水平如何变化,以及如何影响无进展生存期?
Front Oncol. 2023 Mar 29;13:1168996. doi: 10.3389/fonc.2023.1168996. eCollection 2023.
10
Nomograms for predicting overall survival and cancer-specific survival in elderly patients with epithelial ovarian cancer.预测老年上皮性卵巢癌患者总生存和癌症特异性生存的列线图。
J Ovarian Res. 2023 Apr 14;16(1):75. doi: 10.1186/s13048-023-01144-y.